CCK
EW icon

Clarity Capital KCPS’s Edwards Lifesciences EW Stock Holding History

Clarity Capital KCPS’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$296K Buy
+9,450
New +$296K 0.05% 30

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Clarity Capital KCPS's EW Position: Q1 2017 in Review

Clarity Capital KCPS opened a new position in Edwards Lifesciences (EW) in Q1 2017: 9,450 shares worth $296K. The stake represents 0.05% of the portfolio and ranks #30 among its holdings.

690 funds tracked by Wall St. Rank hold EW as of Q1 2017.

  • Clarity Capital KCPS held 9,450 shares of Edwards Lifesciences worth $296K as of Q1 2017.
  • Edwards Lifesciences was a new Clarity Capital KCPS position in Q1 2017.
  • Edwards Lifesciences made up 0.05% of Clarity Capital KCPS's portfolio in Q1 2017, its #30 holding.
  • 690 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2017.

Based on Clarity Capital KCPS's 13F filing for Q1 2017, filed 15 May 2017.